Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2009

Feb 26, 2009

30339_dirs_2009-02-26_b60e314e-25d1-4e27-8445-3947e86c8ac9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2009-02-24

Reporting Person: Filho Fabio de Sampaio Doria (Pres., Europe & Asia Pacific)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-02-24 Stock Option (Right to Buy) $32.09 A 13000 Acquired 2019-02-24 Common Stock (13000) Direct